MoneyWorks4Me

Hester Biosciences informs about conference call

27 Jan 2021 Evaluate
Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Saturday, 30.01.2021 at 2:00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31.12.2020, as attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..